Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02535065
Other study ID # 08-013 Spiral-Z
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date January 27, 2021

Study information

Verified date March 2022
Source Cook Group Incorporated
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Zenith® Low Profile AAA Endovascular Graft Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Low Profile AAA Endovascular Graft used in conjunction with the Zenith® Spiral-Z® AAA Iliac Leg Graft to treat abdominal aortic, aortoiliac, and iliac aneurysms.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date January 27, 2021
Est. primary completion date January 23, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subject has at least one of the following - Aortic or aortoiliac aneurysm - Iliac aneurysm - Aneurysm with a history of growth Exclusion Criteria: - Less than 18 years of age - Inability or refusal to give informed consent - Disease considerations that would compromise patient safety or study outcomes - Pregnant of breastfeeding or planning on becoming pregnant with 60 months - Unwilling to comply with the follow-up schedule

Study Design


Intervention

Device:
Zenith Low Profile AAA Endovascular Graft and ancillary components
Treatment of patients with abdominal aortic, aortoiliac, or iliac aneurysms having morphology suitable for endovascular repair

Locations

Country Name City State
Canada Hamilton General Hospital Hamilton Ontario
United States Summa Akron Akron Ohio
United States Piedmont Hospital Atlanta Georgia
United States University of Colorado Aurora Colorado
United States Bend Memorial Clinic Bend Oregon
United States St. Vincent's Heart and Vascular Center Billings Montana
United States Massachusetts General Boston Massachusetts
United States Cooper University Hospital Camden New Jersey
United States Charleston Area Medical Center Charleston West Virginia
United States Good Samaritan-Trihealth Cincinnati Ohio
United States Morton Plant Hospital Clearwater Florida
United States Missouri Heart Center Columbia Missouri
United States University of Florida Gainesville Florida
United States Hartford Hospital Hartford Connecticut
United States Borgess Research Institute Kalamazoo Michigan
United States Gundersen Lutheran Medical Center La Crosse Wisconsin
United States Baptist Health Louisville Louisville Kentucky
United States Baptist Memorial Hospital-Memphis Memphis Tennessee
United States New York University - Langone Medical Center New York New York
United States Newark Beth Israel Medical Center Newark New Jersey
United States Sentara Vascular Specialists Norfolk Virginia
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania
United States Allegheny General Hospital Pittsburgh Pennsylvania
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania
United States Mayo Clinic Rochester Rochester Minnesota
United States University of Rochester Rochester New York
United States Wm Beaumont Hospital Royal Oak Michigan
United States St. John's Mercy Medical Center Saint Louis Missouri
United States University of Washington-Harborview Medical Center Seattle Washington
United States Stanford University Medical Center Stanford California
United States SUNY at Stony Brook Hospital Stony Brook New York
United States SUNY Upstate Syracuse New York
United States Washington Hospital Center Washington District of Columbia
United States Aspirus Wausau Wausau Wisconsin
United States Iowa Heart Center West Des Moines Iowa
United States Wake Forest Baptist Medical Center Winston-Salem North Carolina
United States University of Massachusetts Medical School Worcester Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Cook Research Incorporated

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients Without Major Adverse Events Within 30 Days Major adverse events include all-cause death, Q-wave MI, renal failure requiring dialysis, paralysis, stroke, bowel ischemia, re-intubation 30 days
Primary Number of Patients With Device Success Device success will be measured with none of the following: type I or III endoleaks requiring re-intervention, graft limb occlusion, aneurysm rupture or conversion to open surgical repair, aneurysm enlargement greater than 0.5 cm 12 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02888613 - Mini-laparotomy Versus Mini Lumbotomy N/A
Recruiting NCT00662480 - Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark Phase 4
Terminated NCT00372138 - Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms N/A
Completed NCT00989729 - Preoperative Methylprednisolone in Endovascular Aortic Repair N/A
Active, not recruiting NCT02345005 - Iliac Branch Excluder ReGistry (IceBERG)
Completed NCT01390740 - Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey
Completed NCT00833924 - Zenith(R) Low Profile AAA Endovascular Graft Clinical Study N/A
Terminated NCT00610090 - Safety Study for the Treatment of Abdominal Aortic Aneurysms Phase 2
Completed NCT02477111 - European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
Recruiting NCT01538056 - Physician Modified Endovascular Grafts N/A
Completed NCT01106391 - A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) N/A
Terminated NCT00444821 - The (PIVOTAL) Study N/A
Completed NCT01599533 - Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm N/A
Completed NCT01328197 - Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms Phase 1
Completed NCT00705718 - Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System N/A
Completed NCT02125890 - Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms Phase 3
Completed NCT00875563 - Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study N/A
Completed NCT02048514 - The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms N/A
Terminated NCT00546013 - Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome N/A
Recruiting NCT05004051 - ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA